Telix to Collaborate with Kettering Health on Diagnostic PSMA Imaging & Targeting Theranostics
Telix announces collaboration with Kettering Health on PSMA-targeting…
Read moreNews & Views
Michael Didocha Joins Telix as Chief Financial Officer, Americas
Telix is delighted to announce the appointment of Michael Didocha as Chief Financial Officer for the Americas…
Read more
Samantha McSherry Joins Telix as Director of Commercial Operations ANZ
Telix is delighted to announce that Samantha McSherry has joined Telix as Director of Commercial Operations for Australia and New…
Read more
Telix and Lightpoint Medical to Collaborate on Radioguided Surgery
Telix announces collaboration with Lightpoint Medical to explore molecularly targeted radiation and Lightpoint SENSEI® in radioguided surgery…
Read more
Half Year Shareholder Update
Telix Pharmaceuticals Limited Announces Half-year Shareholder…
Read more
AUDIO LINK NOT ATTACHED – Telix Half-Year Results 2021 and Company Update Conference Call
Telix announces Half-Year Results 2021 and provides shareholder…
Read more
Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
Telix releases details of two ancillary studies under the ProstACT program, including a Phase II study in collaboration with…
Read more
Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
Telix announces pan-cancer clinical collaboration with Merck KGaA, Darmstadt,…
Read more
Two New Studies to Explore Telix Assets in Breast Cancer Theranostics
Telix announces two new studies to evaluate the potential utility of TLX591-CDx and TLX250-CDx in breast…
Read more
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
Telix extends partnership with AusHealth relating to APOMAB®, a novel theranostic being investigated in lung and ovarian…
Read more